News about Drug Discovery & Development

Elanco Secures USDA Approval for Befrena mAb, Strengthening Canine Dermatology Portfolio

Elanco Animal Health Incorporated has received approval from the US Department of Agriculture (USDA) for Befrena (tirnovetmab), marking the company’s entry into the fast-growing canine dermatology segment with an anti-IL-31 monoclonal antibody therapy for allergic and atopic dermatitis in dogs.

Drug Discovery & Development | 03/01/2026 | By Darshana |  383

CARsgen Advances Allogeneic CAR-T Manufacturing with Dual IND Filings

CARsgen Therapeutics Holdings Limited announced that it has submitted two separate Investigational New Drug (IND) applications to China’s National Medical Products Administration for its allogeneic BCMA-targeted CAR T-cell therapy, CT0596.

Drug Discovery & Development | 30/12/2025 | By Darshana |  149

Nona Biosciences Expands Discovery-to-Clinical Capabilities

Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.

Drug Discovery & Development | 24/12/2025 | By News Bureau |  193

PM Narendra Modi Addresses Closing Ceremony of 2nd WHO Global Summit on Traditional Medicine

Addressing the closing ceremony of the Second WHO Global Summit on Traditional Medicine, Prime Minister Narendra Modi highlighted India’s leadership in traditional healthcare, the global impact of yoga and the establishment of key WHO institutions in Jamnagar and Delhi

Drug Discovery & Development | 20/12/2025 | By News Bureau |  182

Alembic Pharma Gets USFDA Nod for Ophthalmic Suspension With CGT Manufacturing Advantage

The product has been granted Competitive Generic Therapy (CGT) designation, making Alembic eligible for 180 days of market exclusivity in the USA once the product is launched. This exclusivity period provides a significant commercial advantage by limiting competition during initial marketing.

Drug Discovery & Development | 12/12/2025 | By Darshana |  254

MMV Joins iiCON to Boost Infectious Disease Drug Research and Manufacturing Innovation

iiCON, led by the Liverpool School of Tropical Medicine (LSTM), is a global infectious disease R&D programme that unites industry, academic institutions, and clinical bodies to accelerate the development of treatments, diagnostics, and prevention technologies for infectious diseases. Its mission is to save and improve lives.

Drug Discovery & Development | 11/12/2025 | By Darshana |  187

India Broadens Vaccine Partnership as BIRAC - CEPI Deal Extended to mAb Research

The Union Cabinet has approved the renewal and expansion of the strategic partnership between the Biotechnology Industry Research Assistance Council (BIRAC) and the Coalition for Epidemic Preparedness Innovations (CEPI).

Drug Discovery & Development | 07/12/2025 | By Darshana |  192

AstraZeneca Unveils Broadest Haematology Data Set Yet at ASH 2025

AstraZeneca is advancing its ambition to transform haematology care with new data from its expanding pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from 6–9 December 2025.

Drug Discovery & Development | 05/12/2025 | By Darshana |  542

GSK Showcases New Advances in Blood Cancer Treatments

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, reinforcing the potential of its therapies to redefine outcomes for patients with difficult-to-treat blood cancers.

Drug Discovery & Development | 03/12/2025 | By Darshana |  254

JFCR, NEC and Taiho Partner on Whole-Genome Driven Cancer Vaccine Research

JFCR, NEC, and Taiho have launched a joint research initiative to develop novel cancer vaccines using whole-genome data. The project is part of AMED’s national programme on whole-genome analysis, supporting efforts to demonstrate its clinical utility and build systems that translate genomic insights into patient benefits.

Drug Discovery & Development | 01/12/2025 | By Dineshwori |  186